Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population.

Shin MK, Im SH, Park HJ, Kim SK, Yim SV, Chung JH, Lee MH.

Exp Ther Med. 2011 Nov;2(6):1145-1149. Epub 2011 Aug 3.

2.

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

Bouwhuis MG, Gast A, Figl A, Eggermont AM, Hemminki K, Schadendorf D, Kumar R.

Cancer Immunol Immunother. 2010 Feb;59(2):303-12. doi: 10.1007/s00262-009-0751-2.

3.

Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study.

Cunninghame Graham DS, Wong AK, McHugh NJ, Whittaker JC, Vyse TJ.

Hum Mol Genet. 2006 Nov 1;15(21):3195-205. Epub 2006 Sep 25.

4.

Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis.

Kim YO, Kim HJ, Kim SK, Chung JH, Hong SJ.

Clin Chem Lab Med. 2010 Mar;48(3):345-53. doi: 10.1515/CCLM.2010.074.

PMID:
20113255
5.

Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups.

Guzman VB, Morgun A, Shulzhenko N, Mine KL, Gonçalves-Primo A, Musatti CC, Gerbase-Delima M.

Hum Immunol. 2005 Jul;66(7):773-6.

PMID:
16112024
6.

Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.

Karimi MH, Motazedian M, Abedi F, Yaghobi R, Geramizadeh B, Nikeghbalian S.

Gene. 2012 Aug 1;504(1):127-32. doi: 10.1016/j.gene.2012.04.055. Epub 2012 May 11.

PMID:
22579879
7.

No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A.

Scand J Gastroenterol. 2006 May;41(5):586-91.

PMID:
16638702
8.

Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population.

Kim SK, Hong MS, Shin MK, Uhm YK, Chung JH, Lee MH.

Arch Dermatol Res. 2011 Nov;303(9):679-84. doi: 10.1007/s00403-011-1160-x. Epub 2011 Aug 17.

PMID:
21847675
9.

CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population.

Walker EJ, Hirschfield GM, Xu C, Lu Y, Liu X, Lu Y, Coltescu C, Wang K, Newman WG, Bykerk V, Keystone EC, Mosher D, Amos CI, Heathcote EJ, Siminovitch KA.

Arthritis Rheum. 2009 Apr;60(4):931-7. doi: 10.1002/art.24412.

10.

Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma.

Piras G, Monne M, Uras A, Palmas A, Murineddu M, Arru L, Bianchi A, Calvisi A, Curreli L, Gaviano E, Lai P, Murgia A, Latte GC, Noli A, Gabbas A.

Br J Haematol. 2005 Jun;129(6):784-90.

PMID:
15953005
11.

Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population.

Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM, O'morain C, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R.

Genes Immun. 2006 Jan;7(1):19-26.

PMID:
16237465
12.

Genetic polymorphism of the human ICOS gene.

Haimila KE, Partanen JA, Holopainen PM.

Immunogenetics. 2002 Mar;53(12):1028-32. Epub 2002 Feb 6.

PMID:
11904679
13.

Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.

Cheng TY, Lin JT, Chen LT, Shun CT, Wang HP, Lin MT, Wang TE, Cheng AL, Wu MS.

J Clin Oncol. 2006 Jul 20;24(21):3483-9.

14.

Association of TXNDC5 gene polymorphisms and susceptibility to nonsegmental vitiligo in the Korean population.

Jeong KH, Shin MK, Uhm YK, Kim HJ, Chung JH, Lee MH.

Br J Dermatol. 2010 Apr;162(4):759-64. doi: 10.1111/j.1365-2133.2009.09574.x. Epub 2009 Nov 10.

PMID:
19906073
15.

Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo.

Pehlivan S, Ozkinay F, Alper S, Onay H, Yuksel E, Pehlivan M, Ozkinay C.

Eur J Dermatol. 2009 Mar-Apr;19(2):126-8. doi: 10.1684/ejd.2008.0578. Epub 2009 Jan 7.

PMID:
19129082
16.

Immunoregulatory gene polymorphisms in women with preeclampsia.

Pendeloski KP, Sass N, Torloni MR, Mattar R, Moron AF, Franchim CS, Daher S.

Hypertens Res. 2011 Mar;34(3):384-8. doi: 10.1038/hr.2010.247. Epub 2010 Dec 16.

PMID:
21160481
17.

CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.

Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE.

Pigment Cell Res. 2005 Feb;18(1):55-8.

PMID:
15649153
18.

Genetic polymorphisms of the T-cell coreceptors CD28 and CTLA-4 in Afro- and Euro-Brazilians.

Pincerati MR, Dalla-Costa R, Pavoni DP, Petzl-Erler ML.

Int J Immunogenet. 2010 Aug;37(4):253-61. doi: 10.1111/j.1744-313X.2010.00917.x. Epub 2010 Apr 30.

PMID:
20477885
19.

Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients.

Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Park HJ, Park HK, Seo JC, Yim SV, Chung JH, Lee MH.

J Dermatol Sci. 2004 Sep;35(3):181-6.

PMID:
15381239
20.

Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.

Kaartinen T, Lappalainen J, Haimila K, Autero M, Partanen J.

Mol Immunol. 2007 Mar;44(7):1644-51. Epub 2006 Sep 25.

PMID:
16996590
Items per page

Supplemental Content

Write to the Help Desk